HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Hyp(3)-palmitoylLys(16)- glucose-dependent insulinotropic polypeptide

Also Known As:
glucose-dependent insulinotropic polypeptide, Hyp(3)-palmitoylLys(16)-; (Hyp(3))GIPLys(16)PAL; glucose-dependent insulinotropic polypeptide, hydroxyprolyl(3)-palmitoyllysyl(16)-
Networked: 1 relevant articles (0 outcomes, 0 trials/studies)

Bio-Agent Context: Research Results

Experts

1. Bailey, Clifford J: 1 article (06/2007)
2. Flatt, Peter R: 1 article (06/2007)
3. Gault, Victor A: 1 article (06/2007)
4. Green, Brian D: 1 article (06/2007)
5. Greer, Brett: 1 article (06/2007)
6. Harriott, Patrick: 1 article (06/2007)
7. Hunter, Kerry: 1 article (06/2007)
8. Irwin, Nigel: 1 article (06/2007)
9. O'Harte, Finbarr P M: 1 article (06/2007)

Related Diseases

1. Obesity
2. Insulin Resistance

Related Drugs and Biologics

1. Glucose (Dextrose)
2. Hyp(3)- glucose-dependent insulinotropic polypeptide
3. gastric inhibitory polypeptide receptor

Related Therapies and Procedures

1. Injections